Form 4: Ironwood Pharmaceuticals CEO Thomas McCourt Sells Shares to Cover Tax Obligations

Ironwood Pharmaceuticals CEO Thomas McCourt sold 67,618 shares of Class A Common Stock on May 20, 2024, to cover tax withholding obligations related to vesting of restricted stock units.

Summary

• On May 20, 2024, Thomas A. McCourt, CEO of Ironwood Pharmaceuticals, sold 67,618 shares of Class A Common Stock at a price of $6.45 per share.
• The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units and performance-based restricted stock units.
• Following the transaction, McCourt directly owns 1,150,330 shares of Ironwood Pharmaceuticals.
• The sale was not a discretionary trade but an automatic sell-to-cover transaction to satisfy tax obligations.

Sentiment

Score: 6

Explanation: The document reports a routine transaction (sale of shares to cover taxes). It's neutral as it doesn't indicate any fundamental change in the company's prospects or management's confidence.

Management Comments

• The sale occurred automatically to satisfy the tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary trade by the Reporting Person.

Industry Context

Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives and are generally viewed as routine transactions.

Stakeholder Impact

• The sale of shares may have a minor, temporary impact on the stock price, but is unlikely to have a significant long-term effect on shareholders.
• The transaction does not directly impact employees, customers, suppliers, or creditors.

Key Dates